{"id":"1065","presentation":"P-10.3.1 - Wnt Pathway Modulation via CLK2 and DYRK1A Inhibition by Lorecivivint, a Potential Disease-Modifying Treatment for Knee Osteoarthritis","session":"0.0 - Poster Viewing \/ Coffee Break \/ Exhibition","filename":"Deshmukh 10.3.1.pptx","speaker":"S. Kennedy<small> (San Diego, US)<\/small>","photo":"","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-presentations\/icrs2019\/1065\/jpg\/deshmukh10.3.1\/thumbnails\/0.png","html5":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-presentations\/icrs2019\/1065\/html\/deshmukh10.3.1\/data\/","what":"html5","code":"","priority":["html5","pdf","jpg","thumbnail"]}
[speaker]
[presentation]
[session]